ArticleCancer chemotherapy and pharmacology2019

Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.

Ravi Paluri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.